Medication Brand Names Beginning with ‘C’, Page 2

Page 2 of 718 « 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

CABERGOLINE

Cabergoline tablets are indicated for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas. CONTRAINDICATIONS: Cabergoline tablets are contraindicated in patients with: Uncontrolled hypertension or known…

Apotex Corp.12 May 2017

Cabergoline

Cabergoline Tablets are indicated for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas. CONTRAINDICATIONS: Cabergoline Tablets are…

NuCare Pharmaceuticals,Inc.11 October 2018

Cabergoline

Cabergoline Tablets USP are indicated for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas. CONTRAINDICATIONS: Cabergoline Tablets USP are…

REMEDYREPACK INC.23 October 2019

Cabergoline

Cabergoline Tablets are indicated for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas. CONTRAINDICATIONS: Cabergoline Tablets are…

Par Pharmaceutical, Inc.6 November 2019

Cabergoline

Cabergoline Tablets USP are indicated for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas. CONTRAINDICATIONS: Cabergoline Tablets USP are…

Ingenus Pharmaceuticals, LLC19 October 2019

Page 2 of 718 « 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

FDA Medwatch

Fusion Health and Vitality Issues Voluntary Nationwide Recall of Core Essential Nutrients and Immune Boost Sublingual Vitamin D3 Due to the Unapproved Use of a Food Additive and Unapproved Marketing Statements
Sun, 22 Nov 2020. Fusion Health and Vitality LLC is voluntarily recalling all 2020 Lots of CORE essential nutrients and Immune Boost Sublingual Vitamin D3. CORE has been found to contain an unapproved food additive, hordenine HCl, rendering it adulterated. Immune…
Fresenius Kabi Issues Voluntary Nationwide Recall of a Single Lot of Dexmedetomidine Hydrochloride Injection Due to Cross-Contamination of Lidocaine
Wed, 18 Nov 2020. Fresenius Kabi USA is voluntarily recalling a single lot of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg/50 mL (4 mcg /mL), 50 mL fill in a 50 mL vial. Fresenius Kabi initiated this recall due to a trace amount of lidocaine present…

MedLibrary.org

Medication Sections

RSS Feeds

About

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.